Articles with public access mandates - resham bhattacharyaLearn more
OverallNIHDoDNSFAHASNSFUSEDVAHHMIFWFDFGDBTTelethonVersus Arthritis, UKBBSRCBHFCancer Research UKMRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKParkinson's UKWellcomeWorldwide Cancer Research, UKDoris Duke Charitable FoundationDamon Runyon Cancer Research FoundationFlorida Department of Health, USA
Available somewhere: 83
Switching the targeting pathways of a therapeutic antibody by nanodesign
S Bhattacharyya, RD Singh, R Pagano, JD Robertson, R Bhattacharya, ...
Angewandte Chemie 124 (7), 1595-1599, 2012
Mandates: US National Institutes of Health
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
RR Arvizo, S Bhattacharyya, RA Kudgus, K Giri, R Bhattacharya, ...
Chemical Society Reviews 41 (7), 2943-2970, 2012
Mandates: US National Institutes of Health
Cancer nanotechnology: emerging role of gold nanoconjugates
R A Kudgus, R Bhattacharya, P Mukherjee
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2011
Mandates: US National Institutes of Health
Efficient delivery of gold nanoparticles by dual receptor targeting
S Bhattacharyya, JA Khan, GL Curran, JD Robertson, R Bhattacharya, ...
Advanced Materials 23 (43), 5034-5038, 2011
Mandates: US National Institutes of Health
Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge
RR Arvizo, S Rana, OR Miranda, R Bhattacharya, VM Rotello, ...
Nanomedicine: nanotechnology, biology and medicine 7 (5), 580-587, 2011
Mandates: US National Institutes of Health
Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles
RR Arvizo, OR Miranda, DF Moyano, CA Walden, K Giri, R Bhattacharya, ...
PloS one 6 (9), e24374, 2011
Mandates: US National Institutes of Health
Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo
JA Khan, RA Kudgus, A Szabolcs, S Dutta, E Wang, S Cao, GL Curran, ...
PLoS One 6 (6), e20347, 2011
Mandates: US National Institutes of Health
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer
E Wang, S Bhattacharyya, A Szabolcs, C Rodriguez-Aguayo, ...
PloS one 6 (3), e17918, 2011
Mandates: US National Institutes of Health
Inorganic nanoparticles in cancer therapy
S Bhattacharyya, RA Kudgus, R Bhattacharya, P Mukherjee
Pharmaceutical research 28 (2), 237-259, 2011
Mandates: US National Institutes of Health
Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6
V Manickam, A Tiwari, JJ Jung, R Bhattacharya, A Goel, D Mukhopadhyay, ...
Blood, The Journal of the American Society of Hematology 117 (4), 1425-1435, 2011
Mandates: US National Institutes of Health
A core-shell nanomaterial with endogenous therapeutic and diagnostic functions
CR Patra, Y Jing, YH Xu, R Bhattacharya, D Mukhopadhyay, JF Glockner, ...
Cancer nanotechnology 1 (1), 13-18, 2010
Mandates: US National Institutes of Health
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
S Bhattacharyya, R Bhattacharya, S Curley, MA McNiven, P Mukherjee
Proceedings of the national academy of sciences 107 (33), 14541-14546, 2010
Mandates: US National Institutes of Health
Effect of nanoparticle surface charge at the plasma membrane and beyond
RR Arvizo, OR Miranda, MA Thompson, CM Pabelick, R Bhattacharya, ...
Nano letters 10 (7), 2543-2548, 2010
Mandates: US National Institutes of Health
Endothelial cell–specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity
A Verma, R Bhattacharya, I Remadevi, K Li, K Pramanik, GV Samant, ...
blood 115 (22), 4614-4622, 2010
Mandates: US National Institutes of Health
Gold nanoparticles: opportunities and challenges in nanomedicine
R Arvizo, R Bhattacharya, P Mukherjee
Expert opinion on drug delivery 7 (6), 753-763, 2010
Mandates: US National Institutes of Health
Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer
CR Patra, R Bhattacharya, D Mukhopadhyay, P Mukherjee
Advanced drug delivery reviews 62 (3), 346-361, 2010
Mandates: US National Institutes of Health
Sclerostin binds and regulates the activity of cysteine-rich protein 61
TA Craig, R Bhattacharya, D Mukhopadhyay, R Kumar
Biochemical and biophysical research communications 392 (1), 36-40, 2010
Mandates: US National Institutes of Health
Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer
CR Patra, R Bhattacharya, P Mukherjee
Journal of materials chemistry 20 (3), 547-554, 2010
Mandates: US National Institutes of Health
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer
R Bhattacharya, M Nicoloso, R Arvizo, E Wang, A Cortez, S Rossi, ...
Cancer research 69 (23), 9090-9095, 2009
Mandates: US National Institutes of Health
Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2
S Sinha, PK Vohra, R Bhattacharya, S Dutta, S Sinha, D Mukhopadhyay
Journal of cell science 122 (18), 3385-3392, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program